Chronic rejection in renal transplantation

Kreis, 2001, Causes of late renal allograft loss, Transplantation, 71, S5 Halloran, 2002, Call for revolution, Am J Transplant, 2, 195, 10.1034/j.1600-6143.2002.20301.x Mauiyyedi, 2001, Chronic humoral rejection, J Am Soc Nephrol, 12, 574, 10.1681/ASN.V123574 Takemoto, 1991, Transplant risks, Clin Transpl, 325 Hariharan, 2000, Improved graft survival after renal transplantation in the United States, 1988 to 1996, N Engl J Med, 342, 605, 10.1056/NEJM200003023420901 Kasiske, 2002, A thirty percent chronic decline in inverse serum creatinine is an excellent predictor of late renal allograft failure, Am J Kidney Dis, 39, 762, 10.1053/ajkd.2002.31996 Kasiske, 1991, The variable nature of chronic declines in renal allograft function, Transplantation, 51, 330, 10.1097/00007890-199102000-00011 Massy, 1995, Clinical predictors of chronic renal allograft rejection, Kidney Int Suppl, 52, S85 Peschke, 1999, Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients, Clin Nephrol, 51, 290 Ojo, 1998, Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation, Transplantation, 66, 1651, 10.1097/00007890-199812270-00014 Racusen, 1999, The Banff 97 working classification of renal allograft pathology, Kidney Int, 55, 713, 10.1046/j.1523-1755.1999.00299.x Tsamandas, 1997, Significance of tubulitis in chronic allograft nephropathy, Clin Transplant, 11, 391 Sijpkens YWJ, Doxiadis IIN, van Kemenade FJ, et al: Chronic rejection with or without transplant vasculopathy. Clin Transplant (in press) Suri, 2000, Transplant glomerulopathy as a cause of late graft loss, Am J Kidney Dis, 35, 674, 10.1016/S0272-6386(00)70015-1 Andresdottir, 1998, Immunohistological and ultrastructural differences between recurrent type I membranoproliferative glomerulonephritis and chronic transplant glomerulopathy, Am J Kidney Dis, 32, 582, 10.1016/S0272-6386(98)70020-4 Gough, 2001, Peritubular capillary basement membrane reduplication in allografts and native kidney disease, Transplantation, 71, 1390, 10.1097/00007890-200105270-00006 Ivanyi, 2000, Peritubular capillaries in chronic renal allograft rejection, Hum Pathol, 31, 1129, 10.1053/hupa.2000.16677 Shimizu, 2002, Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis, Kidney Int, 61, 1867, 10.1046/j.1523-1755.2002.00309.x Gaweco, 1999, CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection, Kidney Int, 55, 1543, 10.1046/j.1523-1755.1999.00379.x Pilmore, 1999, Vascular endothelial growth factor expression in human chronic renal allograft rejection, Transplantation, 67, 929, 10.1097/00007890-199903270-00024 Mauiyyedi, 2002, Humoral rejection in kidney transplantation, Curr Opin Nephrol Hypertens, 11, 609, 10.1097/00041552-200211000-00007 Regele, 2002, Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries, J Am Soc Nephrol, 13, 2371, 10.1097/01.ASN.0000025780.03790.0F Pedagogos, 1997, Myofibroblast involvement in chronic transplant rejection, Transplantation, 64, 1192, 10.1097/00007890-199710270-00019 Bonsib, 2000, Acute rejection-associated tubular basement membrane defects and chronic allograft nephropathy, Kidney Int, 58, 2206, 10.1111/j.1523-1755.2000.00395.x Grimm, 2001, Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection, N Engl J Med, 345, 93, 10.1056/NEJM200107123450203 Abrass, 1999, Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies, Am J Kidney Dis, 33, 11, 10.1016/S0272-6386(99)70252-0 Lindholm, 1993, The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens, Transplantation, 56, 307, 10.1097/00007890-199308000-00010 van Saase, 1995, The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection, Transplantation, 59, 1280, 10.1097/00007890-199505000-00010 Mueller, 2000, Impact of the Banff ’97 classification for histological diagnosis of rejection on clinical outcome and renal function parameters after kidney transplantation, Transplantation, 69, 1123, 10.1097/00007890-200003270-00017 Herzenberg, 2002, C4d deposition in acute rejection, J Am Soc Nephrol, 13, 234, 10.1681/ASN.V131234 Madden, 2000, Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients, Transpl Int, 13, 344, 10.1111/j.1432-2277.2000.tb01008.x Humar, 2000, Clinical determinants of multiple acute rejection episodes in kidney transplant recipients, Transplantation, 69, 2357, 10.1097/00007890-200006150-00024 Joseph, 2001, The impact of late acute rejection after cadaveric kidney transplantation, Clin Transplant, 15, 221, 10.1034/j.1399-0012.2001.150401.x Sijpkens, 1999, Sharing cross-reactive groups of MHC class I improves long-term graft survival, Kidney Int, 56, 1920, 10.1046/j.1523-1755.1999.00753.x Sijpkens, 2003, Early versus late acute rejection episodes in renal transplantation, Transplantation, 75, 204, 10.1097/01.TP.0000041722.34000.21 Rush, 1998, Beneficial effects of treatment of early subclinical rejection, J Am Soc Nephrol, 9, 2129, 10.1681/ASN.V9112129 Scornik, 1996, Immune responsiveness and renal transplantation, Clin Transpl, 373 Raiz, 1999, Medication compliance following renal transplantation, Transplantation, 68, 51, 10.1097/00007890-199907150-00010 Feldman, 1996, Delayed function reduces renal allograft survival independent of acute rejection, Nephrol Dial Transplant, 11, 1306, 10.1093/ndt/11.7.1306 Massy, 1996, Chronic renal allograft rejection, Kidney Int, 49, 518, 10.1038/ki.1996.74 Young, 2000, Renal transplantation in black Americans, N Engl J Med, 343, 1545, 10.1056/NEJM200011233432107 Flechner, 1996, Determinants of chronic renal allograft rejection in cyclosporine-treated recipients, Transplantation, 62, 1235, 10.1097/00007890-199611150-00009 McKenna, 2000, Anti-HLA antibodies after solid organ transplantation, Transplantation, 69, 319, 10.1097/00007890-200002150-00001 Susal, 2002, Kidney graft failure and presensitization against HLA class I and class II antigens, Transplantation, 73, 1269, 10.1097/00007890-200204270-00014 Davenport, 1994, Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection, Nephrol Dial Transplant, 9, 1315 Piazza, 2001, Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation, Transplantation, 71, 1106, 10.1097/00007890-200104270-00017 Morris, 1999, Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK, Lancet, 354, 1147, 10.1016/S0140-6736(99)01104-6 Smits, 2000, Permanent detrimental effect of nonimmunological factors on long-term renal graft survival, Transplantation, 70, 317, 10.1097/00007890-200007270-00015 Terasaki, 2000, The HLA-matching effect in different cohorts of kidney transplant recipients, Clin Transpl, 497 Opelz, 2001, New immunosuppressants and HLA matching, Transplant Proc, 33, 467, 10.1016/S0041-1345(00)02095-9 Takemoto, 2000, Twelve years’ experience with national sharing of HLA-matched cadaveric kidneys for transplantation, N Engl J Med, 343, 1078, 10.1056/NEJM200010123431504 Kerman, 1993, Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival, Transplantation, 56, 1242, 10.1097/00007890-199311000-00037 McKenna, 1998, Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function, Transplantation, 66, 66, 10.1097/00007890-199807150-00006 Koo, 1999, Cadaver versus living donor kidneys, Kidney Int, 56, 1551, 10.1046/j.1523-1755.1999.00657.x Gjertson, 2000, Impact of delayed graft function and acute rejection on kidney graft survival, Clin Transpl, 467 Giral-Classe, 1998, Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys, Kidney Int, 54, 972, 10.1046/j.1523-1755.1998.00071.x Marcen, 1998, Delayed graft function does not reduce the survival of renal transplant allografts, Transplantation, 66, 461, 10.1097/00007890-199808270-00008 Boom, 2000, Delayed graft function influences renal function, but not survival, Kidney Int, 20, 859, 10.1046/j.1523-1755.2000.00235.x Johnson, 1997, Effect of early cyclosporine levels on kidney allograft rejection, Clin Transplant, 11, 552 Kahan, 1996, Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection, Transplantation, 62, 599, 10.1097/00007890-199609150-00010 De Geest, 1995, Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients, Transplantation, 59, 340, 10.1097/00007890-199502000-00006 Paul, 2001, Glomerular hypertension—An under-appreciated aspect of chronic rejection, Nephrol Dial Transplant, 16, 213, 10.1093/ndt/16.2.213 Terasaki, 1994, The hyperfiltration hypothesis in human renal transplantation, Transplantation, 57, 1450, 10.1097/00007890-199405000-00008 Sanchez-Fructuoso, 2001, Does renal mass exert an independent effect on the determinants of antigen-dependent injury?, Transplantation, 71, 381, 10.1097/00007890-200102150-00007 Gaston, 1996, Impact of donor/recipient size matching on outcomes in renal transplantation, Transplantation, 61, 383, 10.1097/00007890-199602150-00010 Cosio, 1997, Impact of acute rejection and early allograft function on renal allograft survival, Transplantation, 63, 1611, 10.1097/00007890-199706150-00013 Pouteil-Noble, 2000, Post-transplant glomerular filtration rate as a marker for long-term outcome, Ann Transplant, 5, 29 Modena, 1991, Progression of kidney disease in chronic renal transplant rejection, Transplantation, 52, 239, 10.1097/00007890-199108000-00011 Randhawa, 2000, Biopsy of marginal donor kidneys, Transplantation, 69, 1352, 10.1097/00007890-200004150-00024 Halloran, 1999, Rethinking chronic allograft nephropathy, J Am Soc Nephrol, 10, 167, 10.1681/ASN.V101167 Fijter, 2001, Increased immunogenicity and cause of graft loss of old donor kidneys, J Am Soc Nephrol, 12, 1538, 10.1681/ASN.V1271538 Roodnat, 1999, The vanishing importance of age in renal transplantation, Transplantation, 67, 576, 10.1097/00007890-199902270-00015 Kasiske, 2002, Matching older kidneys with older patients does not improve allograft survival, J Am Soc Nephrol, 13, 1067, 10.1681/ASN.V1341067 Terasaki, 1995, High survival rates of kidney transplants from spousal and living unrelated donors, N Engl J Med, 333, 333, 10.1056/NEJM199508103330601 Humar, 1999, Immunologic factors, Transplantation, 68, 1842, 10.1097/00007890-199912270-00004 Knight, 2001, The influence of acute rejection on long-term renal allograft survival, Transplantation, 72, 69, 10.1097/00007890-200107150-00015 Opelz, 1998, Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study, Kidney Int, 53, 217, 10.1046/j.1523-1755.1998.00744.x Mange, 2000, Arterial hypertension and renal allograft survival, JAMA, 283, 633, 10.1001/jama.283.5.633 Cosio, 1999, Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology, Kidney Int, 56, 1912, 10.1046/j.1523-1755.1999.00752.x van Es, 2000, Surrogate markers of chronic allograft nephropathy, Ann Transplant, 5, 7 Barnas, 1997, Parameters associated with chronic renal transplant failure, Nephrol Dial Transplant, 12, 82 Vathsala, 1990, Proteinuria in cyclosporine-treated renal transplant recipients, Transplantation, 49, 35, 10.1097/00007890-199001000-00008 Guijarro, 1995, Clinical correlation between renal allograft failure and hyperlipidemia, Kidney Int Suppl, 52, S56 Isoniemi, 1994, Risk factors predicting chronic rejection of renal allografts, Transplantation, 57, 68, 10.1097/00007890-199401000-00013 Roodnat, 2000, Cholesterol as an independent predictor of outcome after renal transplantation, Transplantation, 69, 1704, 10.1097/00007890-200004270-00029 Wissing, 2000, Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection, Transplantation, 70, 464, 10.1097/00007890-200008150-00012 Bosmans, 2001, Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years, Kidney Int, 59, 2346, 10.1046/j.1523-1755.2001.00752.x Orth, 1997, The renal risks of smoking, Kidney Int, 51, 1669, 10.1038/ki.1997.232 Sung, 2001, Excess risk of renal allograft loss associated with cigarette smoking, Transplantation, 71, 1752, 10.1097/00007890-200106270-00009 de Mattos, 2000, Nephrotoxicity of immunosuppressive drugs, Am J Kidney Dis, 35, 333, 10.1016/S0272-6386(00)70348-9 Sijpkens, 2001, Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral, Clin Nephrol, 55, 149 Takeda A, Uchida K, Haba T, et al: Chronic cyclosporin nephropathy: long-term effects of cyclosporin on renal allografts. Clin Transplant 15(Suppl 5):229 Weir, 2001, Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy, Kidney Int, 59, 1567, 10.1046/j.1523-1755.2001.0590041567.x Briganti, 2002, Risk of renal allograft loss from recurrent glomerulonephritis, N Engl J Med, 347, 103, 10.1056/NEJMoa013036 Cosio, 1999, Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy, Am J Kidney Dis, 34, 731, 10.1016/S0272-6386(99)70400-2 Drachenberg, 2001, Morphological spectrum of polyoma virus disease in renal allografts, Am J Transplant, 1, 373, 10.1034/j.1600-6143.2001.10414.x Hirsch, 2002, Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients, N Engl J Med, 347, 488, 10.1056/NEJMoa020439 Nickeleit, 2000, Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy, N Engl J Med, 342, 1309, 10.1056/NEJM200005043421802 Wong, 1996, Transplant renal artery stenosis in 77 patients—Does it have an immunological cause?, Transplantation, 61, 215, 10.1097/00007890-199601270-00009 Rengel, 1998, Renal artery stenosis after kidney transplantation, Kidney Int Suppl, 68, S99, 10.1038/sj.ki.4490573 Humar, 1998, Isolated iliac artery stenosis as a cause of kidney graft dysfunction post-transplant, Clin Transplant, 12, 406 Baker, 2001, The role of the allograft in the induction of donor-specific T cell hyporesponsiveness, Transplantation, 72, 480, 10.1097/00007890-200108150-00020 Sayegh, 1999, Why do we reject a graft? Role of indirect allorecognition in graft rejection, Kidney Int, 56, 1967, 10.1046/j.1523-1755.1999.00751.x Vella, 1997, Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction, Transplantation, 64, 795, 10.1097/00007890-199709270-00001 Doxiadis, 1996, Association between specific HLA combinations and probability of kidney allograft loss, Lancet, 348, 850, 10.1016/S0140-6736(96)02296-9 Crespo, 2001, Acute humoral rejection in renal allograft recipients, Transplantation, 71, 652, 10.1097/00007890-200103150-00013 Joosten, 2002, Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat, Am J Pathol, 160, 1301, 10.1016/S0002-9440(10)62557-6 Liu, 1993, Contribution of direct and indirect recognition pathways to T cell alloreactivity, J Exp Med, 177, 1643, 10.1084/jem.177.6.1643 Paul, 1999, Chronic allograft nephropathy, Kidney Int, 56, 783, 10.1046/j.1523-1755.1999.00611.x Habib, 1993, Clinical significance of allograft glomerulopathy, Kidney Int Suppl, 43, S95 Chen, 1997, Fate of recurrent acute interstitial cellular rejection in an HLA identical kidney transplant recipient, Clin Nephrol, 48, 300 Nankivell, 2001, Effect of histological damage on long-term kidney transplant outcome, Transplantation, 71, 515, 10.1097/00007890-200102270-00006 Halloran, 1997, The “injury response”, Transplant Proc, 29, 79, 10.1016/S0041-1345(96)00015-2 Morris-Stiff, 1999, Conversion from cyclosporin (Neoral) to tacrolimus (Prograf) in renal allograft recipients with chronic graft nephropathy, Transpl Int, 12, 288, 10.1007/s001470050226 Glicklich, 1998, Chronic renal allograft rejection, Transplantation, 66, 398, 10.1097/00007890-199808150-00019 Theruvath, 2001, Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection, Transplantation, 72, 77, 10.1097/00007890-200107150-00016 Barnas, 1996, The effects of prolonged angiotensin-converting enzyme inhibition on excretory kidney function and proteinuria in renal allograft recipients with chronic progressive transplant failure, Nephrol Dial Transplant, 11, 1822, 10.1093/oxfordjournals.ndt.a027675 Calvino, 2000, Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension, Nephrol Dial Transplant, 15, 82, 10.1093/ndt/15.1.82 Feehally, 1986, Is chronic renal transplant rejection a non-immunological phenomenon?, Lancet, 2, 486, 10.1016/S0140-6736(86)90359-4 Duquesnoy, 2002, HLA matchmaker, Hum Immunol, 63, 339, 10.1016/S0198-8859(02)00382-8 Pollard, 1999, Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients, Transplantation, 68, 1325, 10.1097/00007890-199911150-00018 Mathew, 1998, A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation, Transplantation, 65, 1450, 10.1097/00007890-199806150-00007 Margreiter, 2002, Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation, Lancet, 359, 741, 10.1016/S0140-6736(02)07875-3 Solez, 1998, Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine, Transplantation, 66, 1736, 10.1097/00007890-199812270-00029 Meier-Kriesche, 2003, Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection, Am J Transplant, 3, 68, 10.1034/j.1600-6143.2003.30112.x Kahan, 1999, Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts, Transplantation, 68, 1526, 10.1097/00007890-199911270-00016 Najafian, 2002, Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides, J Am Soc Nephrol, 13, 252, 10.1681/ASN.V131252 Gebauer, 2002, Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool, Am J Transplant, 2, 857, 10.1034/j.1600-6143.2002.20908.x Pascual, 2002, Strategies to improve long-term outcomes after renal transplantation, N Engl J Med, 346, 580, 10.1056/NEJMra011295 Scholten, 2002, Pharmacotherapeutic approach to prevent or treat chronic allograft nephropathy, Current Drug Target, 2, 79